Biostax Corp.
IMUNDelisted Feb 20, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001559356
Biostax Corp. was delisted on Feb 20, 2025; its insiders filed their last Form 4 on Feb 22, 2023; no institution reported holding it in 13F filings for Q2 2023; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q2 2023
- 13F value
- $0
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding IMUN, Q2 2023
No superinvestor reported holding IMUN at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by Biostax Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2023 (view filing)7:00 PM ET | Feb 10 | 12 daysLate | Farmer Glen AChief Financial Officer | PPurchase | +409.0K | $0.045 | +$18.4K | New position409.0K after |
Top 10 13F holders, Q2 2023
The largest institutional positions in Biostax Corp. at the end of Q2 2023; share changes are against Q1 2023.
No institution reported holding IMUN in 13F filings for Q2 2023.